A Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of Biochaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer - NA
Phase of Trial: Phase III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Becaplermin (Primary)
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Virchow Group
- 25 Aug 2016 According to an Adocia media release, the company has initiated a thorough review of the study to analyse the trial data.
- 25 Aug 2016 Top-line results published in an Adocia media release.
- 25 Aug 2016 Status changed from recruiting to completed, according to an Adocia media release.